Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through Medical and Non-Medical segments. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable …
Over the last 12 months, insiders at Integer Holdings Corporation have bought $0 and sold $5.53M worth of Integer Holdings Corporation stock.
On average, over the past 5 years, insiders at Integer Holdings Corporation have bought $323,016 and sold $3.44M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 5,206 shares for transaction amount of $0 was made by Dziedzic Joseph W (President & CEO) on 2022‑12‑31.
2024-07-31 | Sale | director | 4,700 0.0137% | $118.88 | $558,724 | -2.29% | ||
2024-07-31 | Sale | director | 11,960 0.0351% | $119.66 | $1.43M | -2.92% | ||
2024-07-30 | Sale | EVP, Global Ops and Manufactur | 3,400 0.0103% | $123.80 | $420,920 | -6.17% | ||
2024-06-04 | Sale | EVP, Global Ops and Manufactur | 1,521 0.0046% | $120.44 | $183,182 | +6.04% | ||
2024-05-24 | Sale | director | 9,603 0.0288% | $122.44 | $1.18M | +2.85% | ||
2024-05-10 | Sale | President, C&V | 8,712 0.026% | $113.84 | $991,739 | +9.17% | ||
2024-05-07 | Sale | SVP, Strategy and Business Dev | 5,000 0.0151% | $113.14 | $565,708 | +9.88% | ||
2024-05-07 | Sale | EVP, Global Ops and Manufactur | 312 0.0009% | $113.00 | $35,256 | +9.88% | ||
2024-04-30 | Sale | VP, Corporate Controller | 1,500 0.0046% | $114.00 | $171,000 | +10.45% | ||
2023-09-11 | Sale | director | 6,500 0.0196% | $82.32 | $535,061 | +29.09% | ||
2023-06-09 | Sale | director | 3,625 0.0109% | $83.85 | $303,956 | +10.52% | ||
2022-12-31 | President & CEO | 5,206 – | $0 | $0 | +18.39% | |||
2022-12-16 | President & CEO | 4,000 0.0119% | $61.95 | $247,790 | +28.50% | |||
2022-12-01 | Sale | director | 7,018 0.0212% | $74.06 | $519,746 | +8.06% | ||
2022-11-30 | Sale | EVP, Global Operations & ESG | 1,000 0.0029% | $71.16 | $71,160 | +7.62% | ||
2022-08-12 | Sale | President, Electrochem | 2,708 0.0081% | $74.13 | $200,736 | -1.50% | ||
2022-03-02 | Sale | 3,125 0.0094% | $81.26 | $253,938 | -12.70% | |||
2022-01-22 | VP, Corporate Controller | 597 0.0018% | $79.76 | $47,617 | ||||
2021-12-07 | Sale | director | 1,200 0.0037% | $85.38 | $102,460 | -12.72% | ||
2021-12-06 | Sale | director | 7,231 0.0222% | $84.52 | $611,155 | -11.18% |
MAXWELL MARTIN C | director | 20656 0.0616% | $136.30 | 1 | 1 | +85.35% |
Hinrichs James F. | director | 7424 0.0221% | $136.30 | 1 | 1 | +12.4% |
Thomas Tommy P | VP, Corporate Controller | 2813 0.0084% | $136.30 | 1 | 1 | |
Ayliffe John | VP Europe | 13727 0.0409% | $136.30 | 2 | 0 | +6.19% |
MELIA KEVIN C | director | 6150 0.0183% | $136.30 | 1 | 0 | <0.0001% |
BlackRock | $628.48M | 16.08 | 5.39M | -0.35% | -$2.24M | 0.01 | |
The Vanguard Group | $446.43M | 11.42 | 3.83M | +0.61% | +$2.73M | 0.01 | |
Dimensional Fund Advisors | $232.29M | 5.94 | 1.99M | -3.39% | -$8.16M | 0.06 | |
Franklin Templeton Investments | $182.54M | 4.67 | 1.56M | -5.05% | -$9.71M | 0.06 | |
State Street | $151.18M | 3.87 | 1.3M | +0.84% | +$1.26M | 0.01 |